{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:19:49Z","timestamp":1776842389206,"version":"3.51.2"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00c3\u00a1 Agentura \u00c4\u0152esk\u00c3\u00a9 Republiky","doi-asserted-by":"publisher","award":["22-18424M"],"award-info":[{"award-number":["22-18424M"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00c3\u00a1 Agentura \u00c4\u0152esk\u00c3\u00a9 Republiky","doi-asserted-by":"publisher","award":["25-16064S"],"award-info":[{"award-number":["25-16064S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u00c5\u00a0kolstv\u00c3, Ml\u00c3\u00a1de\u00c5\u00bee a T\u00c4\u203alov\u00c3\u00bdchovy","doi-asserted-by":"publisher","award":["CZ.02.01.01\/00\/23_020\/0008499"],"award-info":[{"award-number":["CZ.02.01.01\/00\/23_020\/0008499"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44AI150060"],"award-info":[{"award-number":["R44AI150060"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44AI184034"],"award-info":[{"award-number":["R44AI184034"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000084","name":"Directorate for Engineering","doi-asserted-by":"publisher","award":["1648451"],"award-info":[{"award-number":["1648451"]}],"id":[{"id":"10.13039\/100000084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1013747","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T18:26:51Z","timestamp":1765823211000},"page":"e1013747","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lyme disease control 2.0: Advances and opportunities coming with Lyme disease vaccine VLA15"],"prefix":"10.1371","volume":"21","author":[{"given":"Ondrej","family":"Hajdusek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalvis","family":"Brangulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luise","family":"Robbertse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino Di","family":"Carlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7719-4251","authenticated-orcid":true,"given":"Jan","family":"Perner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"4","key":"ppat.1013747.ref001","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/vbz.2022.0071","article-title":"Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005\u20132020)","volume":"23","author":"L Burn","year":"2023","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"2","key":"ppat.1013747.ref002","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the frequency of Lyme disease diagnoses, United States, 2010\u20132018","volume":"27","author":"KJ Kugeler","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"ppat.1013747.ref003","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3389\/fmicb.2019.01923","article-title":"The RpoS gatekeeper in Borrelia burgdorferi: an invariant regulatory scheme that promotes spirochete persistence in reservoir hosts and niche diversity","volume":"10","author":"MJ Caimano","year":"2019","journal-title":"Front Microbiol"},{"issue":"9","key":"ppat.1013747.ref004","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1128\/IAI.00604-07","article-title":"Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete\u2019s mammal-tick infection cycle","volume":"75","author":"T Bykowski","year":"2007","journal-title":"Infect Immun"},{"issue":"7","key":"ppat.1013747.ref005","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/iai.61.7.2774-2779.1993","article-title":"Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi","volume":"61","author":"RA Kalish","year":"1993","journal-title":"Infect Immun"},{"issue":"24","key":"ppat.1013747.ref006","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.vaccine.2017.04.079","article-title":"Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: implications for vaccine development","volume":"35","author":"JR Izac","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"ppat.1013747.ref007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41541-022-00429-5","article-title":"The year that shaped the outcome of the OspA vaccine for human Lyme disease","volume":"7","author":"RJ Dattwyler","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"5377","key":"ppat.1013747.ref008","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis","volume":"281","author":"DM Gross","year":"1998","journal-title":"Science"},{"issue":"9","key":"ppat.1013747.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184357","article-title":"The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes","volume":"12","author":"P Comstedt","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"ppat.1013747.ref010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1128\/iai.58.4.983-991.1990","article-title":"Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins","volume":"58","author":"ME Brandt","year":"1990","journal-title":"Infect Immun"},{"issue":"11","key":"ppat.1013747.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113294","article-title":"Design and development of a novel vaccine for protection against Lyme borreliosis","volume":"9","author":"P Comstedt","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"ppat.1013747.ref012","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1080\/14760584.2022.2102484","article-title":"Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights","volume":"21","author":"W-H Chen","year":"2022","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"ppat.1013747.ref013","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.183.1.271","article-title":"Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine","volume":"183","author":"AM de Silva","year":"1996","journal-title":"J Exp Med"},{"issue":"11","key":"ppat.1013747.ref014","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1128\/IAI.00410-08","article-title":"Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector","volume":"76","author":"JM Battisti","year":"2008","journal-title":"Infect Immun"},{"issue":"4","key":"ppat.1013747.ref015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group","volume":"339","author":"AC Steere","year":"1998","journal-title":"N Engl J Med"},{"issue":"9","key":"ppat.1013747.ref016","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1473-3099(25)00092-1","article-title":"Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trial","volume":"25","author":"L Wagner","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"ppat.1013747.ref017","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1473-3099(25)00160-4","article-title":"Lyme borreliosis vaccine VLA15 tested safe and immunogenic in children and adolescents","volume":"25","author":"O Hajdusek","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"23","key":"ppat.1013747.ref018","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3390\/diagnostics14232704","article-title":"Significance of detecting serum antibodies to outer surface protein A of Lyme disease borreliae in PCR-confirmed blood infections","volume":"14","author":"JS Shah","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"ppat.1013747.ref019","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/IAI.67.1.173-181.1999","article-title":"The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis","volume":"67","author":"E Akin","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"ppat.1013747.ref020","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00018-19","article-title":"Laboratory diagnosis of Lyme Borreliosis","volume":"34","author":"JA Branda","year":"2021","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"ppat.1013747.ref021","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cid\/cix043","article-title":"Evaluation of modified 2-tiered serodiagnostic testing algorithms for early Lyme disease","volume":"64","author":"JA Branda","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ppat.1013747.ref022","doi-asserted-by":"crossref","first-page":"102097","DOI":"10.1016\/j.xcrm.2025.102097","article-title":"Diagnostic validation of novel Borrelia antigens discovered by whole-proteome microarray: advancing early detection and test of cure for Lyme disease","volume":"6","author":"A Nayak","year":"2025","journal-title":"Cell Rep Med"},{"issue":"8","key":"ppat.1013747.ref023","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/pathogens11080944","article-title":"Linear peptide epitopes derived from ErpP, p35, and FlaB in the serodiagnosis of Lyme disease","volume":"11","author":"PM Arnaboldi","year":"2022","journal-title":"Pathogens"},{"issue":"1","key":"ppat.1013747.ref024","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1038\/s41467-024-51067-5","article-title":"Rapid single-tier serodiagnosis of Lyme disease","volume":"15","author":"R Ghosh","year":"2024","journal-title":"Nat Commun"},{"issue":"10","key":"ppat.1013747.ref025","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S1473-3099(23)00210-4","article-title":"Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults","volume":"23","author":"N B\u00e9zay","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"ppat.1013747.ref026","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1473-3099(24)00175-0","article-title":"Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies","volume":"24","author":"N B\u00e9zay","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"ppat.1013747.ref027","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S1473-3099(24)00372-4","article-title":"Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial","volume":"24","author":"SK Ghadge","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"ppat.1013747.ref028","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1128\/IAI.01950-05","article-title":"Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection","volume":"74","author":"K Tilly","year":"2006","journal-title":"Infect Immun"},{"key":"ppat.1013747.ref029","doi-asserted-by":"crossref","first-page":"100079","DOI":"10.1016\/j.jvacx.2020.100079","article-title":"VANGUARD\u00aecrLyme: a next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogs","volume":"6","author":"RT Marconi","year":"2020","journal-title":"Vaccine X"},{"issue":"1","key":"ppat.1013747.ref030","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/s41467-025-58182-x","article-title":"Mechanistic insights into the structure-based design of a CspZ-targeting Lyme disease vaccine","volume":"16","author":"K Brangulis","year":"2025","journal-title":"Nat Commun"},{"issue":"11","key":"ppat.1013747.ref031","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1473-3099(24)00412-2","article-title":"Boosting immunity to protect from tickborne Lyme disease","volume":"24","author":"N Baumgarth","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"ppat.1013747.ref032","doi-asserted-by":"crossref","first-page":"219","DOI":"10.14745\/ccdr.v48i05a05","article-title":"Surveillance for Lyme disease in Canada, 2009\u20132019","volume":"48","author":"S Gasmi","year":"2022","journal-title":"Can Commun Dis Rep"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T18:26:56Z","timestamp":1765823216000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013747"}},"subtitle":[],"editor":[{"given":"John M","family":"Leong","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1013747","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}